Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2003
10/09/2003US20030190667 Identification and isolation of DNA and recombinant production of polypeptides
10/09/2003US20030190643 Sequencing by mass spectrometry
10/09/2003US20030190639 Diagnosis of Cryptogenetic inflammatory bowel diseases (IBDs)
10/09/2003US20030190611 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190610 Proteins involved in differentiation, maintenance of multicellular organisms, e.g. proliferation, migration, interaction of cells through drugs
10/09/2003US20030190606 Hepatitis C virus NS5B truncated protein and methods thereof to identify antiviral compounds
10/09/2003US20030190601 Useful for diagnosis and therapy, research tools for drug discovery
10/09/2003US20030190324 Immunologically significant herpes simplex virus antigens and methods for using same
10/09/2003CA2762016A1 Methods for increasing polypeptide production
10/09/2003CA2481376A1 Novel proteins and nucleic acids encoding same
10/09/2003CA2480525A1 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
10/09/2003CA2480319A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
10/09/2003CA2480178A1 Methods for producing secreted polypeptides having l-asparaginase activity
10/09/2003CA2480159A1 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
10/09/2003CA2448540A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/08/2003EP1350846A1 C-terminal modified protein and process for producing the same, modifying agent and translation template to be used in produfing c-terminal modified protein, and method of detecting protein interaction with the use of c-termial modified protein
10/08/2003EP1350845A1 Molecule correspondent to genotype and phenotype, composing elements thereof, method of producing the corespondent molecule and method of using the same
10/08/2003EP1350838A1 Expression of recombinant human proteins in Tetrahymena
10/08/2003EP1350799A2 Inhibitory Immunoglobulin Polypeptides to Human PDGF Beta Receptor
10/08/2003EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays
10/08/2003EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays
10/08/2003EP1350105A2 Immunoassays for anti-hcv antibodies
10/08/2003EP1350104A2 Presenilin enhancers
10/08/2003EP1350085A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
10/08/2003EP1349955A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
10/08/2003EP1349945A2 Method for the production of a heterologous protein by a fungus
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349940A2 55562 and 21617, novel human proteins and methods of use thereof
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same
10/08/2003EP1349931A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0865448B1 Apoptosis induced by monoclonal antibody anti-her2
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447857A Agonist anti-TRK-C monoclonal antibodies
10/08/2003CN1446911A Method for producing protease of thermophilic bacteria by using artificial gene
10/08/2003CN1123574C Ligands for FLT3 receptors
10/07/2003USH2085 High molecular weight polypeptides used to screen for enzyme inhibitors, such as transferases, hydrolases or proteolytic enzymes; antibiotic resistance
10/07/2003US6630616 Arabidopsis MPC1 gene and methods for controlling flowering time
10/07/2003US6630613 Mouse whose genome comprises a disruption of large tumor suppressor (lats) protein; use in treatment of cancer and hyperproliferative disorders; use antagonists in growing larger animals and plants
10/07/2003US6630584 DNA molecule of given sequence; specifically binds to given hexapeptide; use in treatment of cancer
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630450 Method of treating dyslipidemia
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630443 Detecting agonists and antagonists; treating under- and overexpression
10/07/2003US6630350 Monoclonal antibodies against a human act and serine protease complex
10/07/2003US6630331 Isolated DNA encoding a protein from Lotus japonicus which has pantothenate synthetase activity; enzyme inhibitors
10/07/2003US6630328 Increasing production of proteins in gram-positive microorganisms
10/07/2003US6630327 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630320 Prepared with trypsin; oral administration; given physical properties
10/07/2003US6630315 Adsorbing bacterial toxins by contacting with a material having an immobilizing carrier; use in detecting exotoxins in blood and urine and in treatment of sepsis and autoimmune diseases
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630298 HCV antigen/antibody combination assay
10/07/2003US6630297 Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target
10/07/2003US6630147 Pseudomycin natural products
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/02/2003WO2003081252A1 Arrays
10/02/2003WO2003081241A1 Attachment of biomolecules to hydrophobic surfaces
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080852A1 Process for the preparation of a desired erythropoietin glyco-isoform profile
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080830A1 Modified promoter
10/02/2003WO2003080821A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080802A2 Nucleic acid constructs and methods for producing altered seed oil compositions
10/02/2003WO2003080796A2 Ordered biological nanostructures formed from chaperonin polypeptides
10/02/2003WO2003080676A1 Antibody against transferrin-containing immune complex, process for producing the antibody, hybridoma and immunoassay method
10/02/2003WO2003080674A1 Antibody disulfide isomers, use thereof, and methods of analyzing same
10/02/2003WO2003080670A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003079805A1 Cross-linked gelatin
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003046180A3 Human cdnas and proteins and uses thereof
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003020938A3 Method of protein production in plants
10/02/2003WO2003020767A3 Antibodies against caspase-8, their preparation and use
10/02/2003WO2003010194A3 Meningococcus adhesins nada, app and orf 40
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002068597A3 Enzymes having alpha amylase activity and methods of use thereof
10/02/2003WO2002008383A3 Sp110, a polypeptide component of the nuclear body
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001005355A3 Formulations for il-11
10/02/2003US20030188335 Chimeric & endotoxin protein with extraordinarily high insecticidal activity
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 1125